ZURICH, Aug 19 (Reuters) - Swiss drugmaker Roche Holding on Monday named Eli Lilly executive Levi Garraway to succeed Sandra Horning as chief medical officer and head of global product development.
Garraway, most recently Eli Lilly’s senior vice president, oncology research and development and Lilly research laboratories novel target research, will take up the post as of Oct. 1 and be based in South San Francisco.
Horning will retire as of the end of 2019. (Reporting by John Miller, Writing by Michael Shields. Editing by Jane Merriman)